tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IGXT Stock Latest News

IntelGenx Trials Novel Parkinson’s Treatment
Company AnnouncementsIntelGenx Trials Novel Parkinson’s Treatment
12d ago
IGXT
IntelGenx doses first patients in Phase 2 ‘MONTPARK’ trial
PremiumThe Fly
IntelGenx doses first patients in Phase 2 ‘MONTPARK’ trial
12d ago
IGXT
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
PremiumPress Releases
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
12d ago
IGXT
IntelGenx Faces FDA Hurdle for Pain Management Drug
PremiumCompany Announcements
IntelGenx Faces FDA Hurdle for Pain Management Drug
15d ago
IGXT
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
PremiumPress Releases
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
15d ago
IGXT
IntelGenx says Chemo Research receeives CRL on Buprenorphine Buccal Film ANDA
PremiumThe FlyIntelGenx says Chemo Research receeives CRL on Buprenorphine Buccal Film ANDA
15d ago
IGXT
IntelGenx Foresees Revenue Growth with RIZAFILM Launch
PremiumCompany Announcements
IntelGenx Foresees Revenue Growth with RIZAFILM Launch
30d ago
IGXT
IntelGenx reports Q4 EPS (1c) vs (1c) last year
PremiumThe Fly
IntelGenx reports Q4 EPS (1c) vs (1c) last year
30d ago
IGXT
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
PremiumPress Releases
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
30d ago
IGXT
IntelGenx Set to Unveil 2023 Financial Results
PremiumCompany Announcements
IntelGenx Set to Unveil 2023 Financial Results
1M ago
IGXT
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
PremiumPress Releases
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
1M ago
IGXT
IntelGenx Boosts Finances with Revised atai Agreement
PremiumCompany Announcements
IntelGenx Boosts Finances with Revised atai Agreement
1M ago
IGXT
IntelGenx enters amended, restated loan agreement with atai Life Sciences
PremiumThe FlyIntelGenx enters amended, restated loan agreement with atai Life Sciences
1M ago
ATAI
IGXT
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
PremiumPress Releases
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
1M ago
IGXT
IntelGenx Partners with Digital Offering for Stock Sale
PremiumCompany Announcements
IntelGenx Partners with Digital Offering for Stock Sale
2M ago
8K
IGXT
UPDATE — IntelGenx Launches Preferred Share Regulation A Offering
PremiumPress Releases
UPDATE — IntelGenx Launches Preferred Share Regulation A Offering
2M ago
IGXT
IntelGenx Launches Preferred Share Regulation A Offering
PremiumPress Releases
IntelGenx Launches Preferred Share Regulation A Offering
2M ago
IGXT
IntelGenx Issues Preferred Stock with Dividend Priorities
PremiumCompany Announcements
IntelGenx Issues Preferred Stock with Dividend Priorities
2M ago
8K
IGXT
IntelGenx announces results from POC study of VetaFilm platform
PremiumThe Fly
IntelGenx announces results from POC study of VetaFilm platform
2M ago
IGXT
IntelGenx enters development, license agreement for VetaFilm
PremiumThe FlyIntelGenx enters development, license agreement for VetaFilm
4M ago
IGXT
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
PremiumPress Releases
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
4M ago
IGXT
IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000
PremiumPress Releases
IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000
5M ago
IGXT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >